REGISTERED NUMBER: |
THE EMERALD CLINIC LIMITED |
UNAUDITED FINANCIAL STATEMENTS |
FOR THE PERIOD 5 JULY 2023 TO 31 MARCH 2024 |
REGISTERED NUMBER: |
THE EMERALD CLINIC LIMITED |
UNAUDITED FINANCIAL STATEMENTS |
FOR THE PERIOD 5 JULY 2023 TO 31 MARCH 2024 |
THE EMERALD CLINIC LIMITED (REGISTERED NUMBER: 14981291) |
CONTENTS OF THE FINANCIAL STATEMENTS |
FOR THE PERIOD 5 JULY 2023 TO 31 MARCH 2024 |
Page |
Company Information | 1 |
Abridged Balance Sheet | 2 | to | 3 |
Notes to the Financial Statements | 4 | to | 5 |
THE EMERALD CLINIC LIMITED |
COMPANY INFORMATION |
FOR THE PERIOD 5 JULY 2023 TO 31 MARCH 2024 |
DIRECTOR: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
ACCOUNTANTS: |
Chartered Accountants |
7 Jardine House |
Harrovian Business Village |
Bessborough Road |
Harrow |
Middlesex |
HA1 3EX |
THE EMERALD CLINIC LIMITED (REGISTERED NUMBER: 14981291) |
ABRIDGED BALANCE SHEET |
31 MARCH 2024 |
Notes | £ | £ |
FIXED ASSETS |
Tangible assets | 4 |
CURRENT ASSETS |
Cash at bank |
CREDITORS |
Amounts falling due within one year |
NET CURRENT LIABILITIES | ( |
) |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CREDITORS |
Amounts falling due after more than one year |
NET LIABILITIES | ( |
) |
CAPITAL AND RESERVES |
Called up share capital |
Retained earnings | ( |
) |
SHAREHOLDERS' FUNDS | ( |
) |
The director acknowledges her responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
THE EMERALD CLINIC LIMITED (REGISTERED NUMBER: 14981291) |
ABRIDGED BALANCE SHEET - continued |
31 MARCH 2024 |
The financial statements were approved by the director and authorised for issue on |
THE EMERALD CLINIC LIMITED (REGISTERED NUMBER: 14981291) |
NOTES TO THE FINANCIAL STATEMENTS |
FOR THE PERIOD 5 JULY 2023 TO 31 MARCH 2024 |
1. | STATUTORY INFORMATION |
The Emerald Clinic Limited is a |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Turnover |
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
Tangible fixed assets |
Plant and machinery | - |
Taxation |
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current or deferred taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference. |
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
Going concern |
The financial statements have been prepared on a going concern basis. The directors have considered the company’s ability to continue as a going concern, including an assessment of current and future financial performance, cash flows, and financial position. |
In making this assessment, the directors have taken into account a variety of factors, including the company's financial position as at the balance sheet date, budget forecasts for the forthcoming year, and any potential risks or uncertainties that may affect the company's ability to meet its obligations as they fall due. |
Based on this assessment, the directors are satisfied that the company has, and will continue to have, adequate resources to continue in operational existence for the foreseeable future. Accordingly, the directors have prepared the financial statements on a going concern basis |
THE EMERALD CLINIC LIMITED (REGISTERED NUMBER: 14981291) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE PERIOD 5 JULY 2023 TO 31 MARCH 2024 |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the period was NIL. |
4. | TANGIBLE FIXED ASSETS |
Totals |
£ |
COST |
Additions |
At 31 March 2024 |
DEPRECIATION |
Charge for period |
At 31 March 2024 |
NET BOOK VALUE |
At 31 March 2024 |
5. | SECURED DEBTS |
The following secured debts are included within creditors: |
£ |
Hire purchase contracts | 69,333 |
6. | ULTIMATE CONTROLLING PARTY |
The controlling party is Mrs D Gill. |